Diofan® Ultra736 is fluorine-free, meets regulatory requirements for direct pharmaceutical contact and supports the design of sustainable films with thinner coating designs. 

Winning entry suggests replacing the plastic and aluminum often used in medication packaging with paperboard.

Activ-Blister active packaging solutions deliver enhanced product stability and expedited speed-to-market for oral solid dose drugs in the EU.

Amcor’s new AmSky blister packaging uses HDPE throughout for curbside recycling.

Astellas uses biomass-based plastics made from plant-derived materials in blister packages as the primary packaging for pharmaceutical products.

ecoCombo™ compliments Rohrer’s ezCombo™ program and offers a new way for retail brands to make sustainable packaging choices in their blister packaging.

The Alloyd Division of Sonoco has introduced its first, all-paper retail blister package. 

In 1970, Richard Nixon signed into law the Poison Prevention Packaging Act (PPPA). The act was written in response to a growing number of child poisonings from unintentional ingestion of drugs and other products. The Act was successful, but a lot has changed in the last 47 years.

A fall 2016 report by Research and Markets states the cold form blister packaging market should hit U.S. $8.63 billion by 2024. Growing demand from the pharmaceutical industry and a high requirement of cold forming packs due to favorable product features are driving the growth.

It’s 2017! If you are expecting groundbreaking news from the world of pharmaceutical safety, you may have to wait a while. Let’s get a quick status report.